Paolo V. Troia-Cancio, M.D., F.A.C.P. for UC Davis Health

Paolo V. Troia-Cancio, M.D., F.A.C.P.

Associate Physician UC Davis Community Physicians

HS Clinical Professor, Division of Infectious Disease

To see if Paolo V. Troia-Cancio is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Reviews

Specialties

Internal Medicine

Infectious Diseases

Locations and Contact

UC Davis Medical Group - Elk Grove

UC Davis Medical Group - Elk Grove
8110 Laguna Blvd.
Elk Grove, CA 95758

Get Directions

One Community Health (formerly Cares Community Health)

One Community Health (formerly Cares Community Health)
1500 21st St.
Sacramento, CA 95817

Get Directions

Additional Numbers

Clinic Phone

916-443-3299

Clinic Phone

916-683-3955

Clinic Fax

916-683-7290

Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

I strive to treat my patients with comprehensive, compassionate, and non-judgmental comprehensive care. I want to build a partnernship and empower my patients with the knowledge to make the best health choices.

Clinical Interests

Dr. Troia-Cancio is an Internal Medicine and Infectious Disease Specialist offering care for individuals 18 and older. He has special clinical interest and expertise in adult primary care, primary care for gender minorities, HIV primary and specialty care, and treatment of Hepatitis C infection.

Research/Academic Interests

Dr. Troia-Cancio's research interests are HIV Clinical Trials.

Division

Infectious Diseases

Center/Program Affiliation

UC Davis Medical Group

Undergraduate School

B.A., Johns Hopkins University, Baltimore MD 1990

Medical School

M.D., University of Puerto Rico School of Medicine, San Juan PR 1995

Internship

Internal Medicine, UT Southwestern Medical Center, Dallas TX 1995-1996

Residency

Internal Medicine, UT Southwestern Medical Center, Dallas TX 1996-1998

Fellowship

Infectious Diseases, UT Southwestern Medical Center, Dallas TX 1998-2000

Alpha Omega Alpha, 1995

To view Dr. Troia-Cancio's publications, please click here.

Troia-Cancio P, Asmuth DM. Lessons from maraviroc clinical trials. Expert Rev Anti Infect Ther. 2011 Jun;9(6):649-51. doi:10.1586/eri.11.52. Erratum in: Expert Rev Anti Infect Ther. 2011 Aug;9(8):698. PMID:21692669.

Sainz T, Serrano-Villar S, Mann S, Ma ZM, Utay NS, Thompson CG, Chun TW, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Moreno S, Pollard RB, Landay A, Miller CJ, Asmuth DM. Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy. AIDS. 2019 Dec 1;33(15):2289-2298. doi:10.1097/QAD.0000000000002361. PMID:31764094.

Melikian GL, Rhee SY, Taylor J, Fessel WJ, Kaufman D, Towner W, Troia-Cancio PV, Zolopa A, Robbins GK, Kagan R, Israelski D, Shafer RW. Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility. Antimicrob Agents Chemother. 2012 May;56(5):2305-13. doi:10.1128/AAC.05487-11. Epub 2012 Feb 13. PMID:22330916.

Scribner AN, Troia-Cancio PV, Cox BA, Marcantonio D, Hamid F, Keiser P, Levi M, Allen B, Murphy K, Jones RE, Skiest DJ. Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):19-25. doi:10.1097/00042560-200009010-00003. PMID:11064500.

Asmuth DM, Pinchuk IV, Wu J, Vargas G, Chen X, Mann S, Albanese A, Ma ZM, Saroufeem R, Melcher GP, Troia-Cancio P, Torok NJ, Miller CJ, Powell DW. Role of intestinal myofibroblasts in HIV-associated intestinal collagen deposition and immune reconstitution following combination antiretroviral therapy. AIDS. 2015 May 15;29(8):877-88. doi:10.1097/QAD.0000000000000636. PMID:25784439.

Asmuth DM, Thompson CG, Chun TW, Ma ZM, Mann S, Sainz T, Serrano-Villar S, Utay NS, Garcia JC, Troia-Cancio P, Pollard RB, Miller CJ, Landay A, Kashuba AD. Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy. J Infect Dis. 2017 Oct 17;216(7):813-818. doi:10.1093/infdis/jix418. PMID:28968888.

Brown J, Fleming CS, Troia-Cancio PV. Arcanobacterium haemolyticum osteomyelitis and sepsis: a diagnostic conundrum. Surg Infect (Larchmt). 2013 Jun;14(3):322-4. doi:10.1089/sur.2011.129. Epub 2013 Apr 12. PMID:23581632.

Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016 Jan 21;12(1):e1005381. doi:10.1371/journal.ppat.1005381. Erratum in: PLoS Pathog. 2016 Mar;12(3):e1005540. Wook-Chun, Tae [corrected to Chun, Tae-Wook]. Erratum in: PLoS Pathog. 2017 May 3;13(5):e1006368. PMID:26795282.

Asmuth DM, Ma ZM, Mann S, Knight TH, Yotter T, Albanese A, Melcher GP, Troia-Cancio P, Hayes T, Miller CJ, Pollard RB. Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens. AIDS. 2012 Aug 24;26(13):1625-34. doi:10.1097/QAD.0b013e3283546595. PMID:22820612.